Wade Thorstad

Medicine & Life Sciences

1. Squamous Cell Carcinoma 100%
2. Radiotherapy 94%
3. Survival 62%
4. Oropharyngeal Neoplasms 59%
5. Squamous Cell Carcinoma of Head and Neck 53%
6. Neck 45%
7. Head and Neck Neoplasms 40%
8. Neoplasms 39%
9. Radiation 34%
10. Recurrence 34%
11. Head 29%
12. 130-nm albumin-bound paclitaxel 24%
13. Induction Chemotherapy 24%
14. Cisplatin 24%
15. Radiation Oncology 23%
16. Cetuximab 23%
17. Tumor Burden 19%
18. Neoplasm Metastasis 18%
19. Therapeutics 18%
20. Carcinoma 18%
21. Merkel Cell Carcinoma 17%
22. Disease-Free Survival 16%
23. Extranodal Extension 15%
24. Oropharynx 15%
25. Confidence Intervals 14%
26. Neck Dissection 13%
27. Lymph Nodes 12%
28. Datasets 12%
29. Papillomaviridae 11%
30. Intensity-Modulated Radiotherapy 11%
31. Nomograms 11%
32. TP protocol 11%
33. MicroRNAs 10%
34. Progression-Free Survival 10%
35. In Situ Hybridization 9%
36. Fluorouracil 9%
37. Tomography 9%
38. Larynx 9%
39. Artifacts 9%
40. Amifostine 9%
41. Xerostomia 8%
42. Skin Neoplasms 8%
43. pembrolizumab 8%
44. Salivary Glands 8%
45. Iodine-131 8%
46. Non-Small Cell Lung Carcinoma 8%
47. Smoking 8%
48. Drug Therapy 8%
49. Metals 8%
50. Margins of Excision 7%